Redhill Biopharma’s Pipeline Gains Momentum Amid Stock Volatility
Redhill Biopharma’s pipeline, from opaganib for COVID-19 to RHB-104 for Crohn’s, shows promise amid tough market conditions—investors watch closely.
2 minutes to read
Redhill Biopharma Ltd